Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications
- PMID: 17691957
- DOI: 10.2174/092986707781389646
Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications
Abstract
Cardiac failure is a leading cause for the mortality of diabetic patients, in part due to a specific cardiomyopathy, referred to as diabetic cardiomyopathy, which occurs with or without co-existence of vascular diseases. Although several mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stress is widely considered as one of the major causes for the pathogenesis of the disease. Thus, a few laboratories are trying to develop antioxidants used to prevent diabetic cardiomyopathy. Metallothioneins (MTs) are cysteine-rich metal-binding proteins with several biological roles including antioxidant property. We and others have indicated the significant cardiac protection of MT against diabetes using cardiac-specific MT-overexpressing transgenic mice and OVE26MT mice (cross-bred of cardiac MT transgenic mice with genetically engineered diabetic OVE26 mice). Several possible mechanisms responsible for MT's cardiac protection from diabetes were revealed. These include MT's important roles in calcium regulation, zinc homeostasis, insulin sensitization, and antioxidant action. Since MT is ubiquitously expressed in mammalian tissues and is highly inducible by a variety of reagents such as zinc, the clinical potential for inducing cardiac MT as an antioxidant by zinc supplementation to prevent various diabetic complications, including cardiomyopathy, has been explored in diabetic animal models and patients. Since zinc has been therapeutically used for several other non-diabetic diseases in clinics, it provides further potential use of zinc for diabetic patients. Therefore, this review will briefly introduce the biochemical features of MT along with its critical roles in redox homeostasis and antioxidant function in the heart, and then discuss the current research on the prevention of diabetic cardiomyopathy by MT with an emphasis on experimental evidence, possible mechanisms, and clinical implications.
Similar articles
-
Overexpression of metallothionein reduces diabetic cardiomyopathy.Diabetes. 2002 Jan;51(1):174-81. doi: 10.2337/diabetes.51.1.174. Diabetes. 2002. PMID: 11756338
-
Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.Circulation. 2006 Jan 31;113(4):544-54. doi: 10.1161/CIRCULATIONAHA.105.537894. Epub 2006 Jan 23. Circulation. 2006. PMID: 16432057
-
Diabetes and metallothionein.Mini Rev Med Chem. 2007 Jul;7(7):761-8. doi: 10.2174/138955707781024490. Mini Rev Med Chem. 2007. PMID: 17627587 Review.
-
Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.J Am Coll Cardiol. 2006 Oct 17;48(8):1688-97. doi: 10.1016/j.jacc.2006.07.022. Epub 2006 Sep 27. J Am Coll Cardiol. 2006. PMID: 17045908
-
Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy.Free Radic Biol Med. 2006 Sep 15;41(6):851-61. doi: 10.1016/j.freeradbiomed.2006.06.007. Epub 2006 Jun 15. Free Radic Biol Med. 2006. PMID: 16934665 Review.
Cited by
-
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy.Free Radic Biol Med. 2021 Jun;169:317-342. doi: 10.1016/j.freeradbiomed.2021.03.046. Epub 2021 Apr 25. Free Radic Biol Med. 2021. PMID: 33910093 Free PMC article. Review.
-
Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.Redox Biol. 2018 Oct;19:11-21. doi: 10.1016/j.redox.2018.07.014. Epub 2018 Jul 21. Redox Biol. 2018. PMID: 30096613 Free PMC article.
-
Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation.Int J Mol Sci. 2016 Nov 8;17(11):1853. doi: 10.3390/ijms17111853. Int J Mol Sci. 2016. PMID: 27834824 Free PMC article. Review.
-
Electric Pulse Stimulation of Myotubes as an In Vitro Exercise Model: Cell-Mediated and Non-Cell-Mediated Effects.Sci Rep. 2015 Jun 19;5:10944. doi: 10.1038/srep10944. Sci Rep. 2015. PMID: 26091097 Free PMC article.
-
Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice.J Cell Mol Med. 2021 Jul;25(14):6828-6840. doi: 10.1111/jcmm.16687. Epub 2021 May 30. J Cell Mol Med. 2021. PMID: 34053181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical